These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 27849360

  • 1. Robust Reductions of Excess Weight and Hyperphagia by Beloranib in Rat Models of Genetic and Hypothalamic Obesity.
    Elfers CT, Roth CL.
    Endocrinology; 2017 Jan 01; 158(1):41-55. PubMed ID: 27849360
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial.
    McCandless SE, Yanovski JA, Miller J, Fu C, Bird LM, Salehi P, Chan CL, Stafford D, Abuzzahab MJ, Viskochil D, Barlow SE, Angulo M, Myers SE, Whitman BY, Styne D, Roof E, Dykens EM, Scheimann AO, Malloy J, Zhuang D, Taylor K, Hughes TE, Kim DD, Butler MG.
    Diabetes Obes Metab; 2017 Dec 01; 19(12):1751-1761. PubMed ID: 28556449
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial.
    Proietto J, Malloy J, Zhuang D, Arya M, Cohen ND, de Looze FJ, Gilfillan C, Griffin P, Hall S, Nathow T, Oldfield GS, O'Neal DN, Roberts A, Stuckey BGA, Yue D, Taylor K, Kim D.
    Diabetologia; 2018 Sep 01; 61(9):1918-1922. PubMed ID: 29992370
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial.
    Kim DD, Krishnarajah J, Lillioja S, de Looze F, Marjason J, Proietto J, Shakib S, Stuckey BGA, Vath JE, Hughes TE.
    Diabetes Obes Metab; 2015 Jun 01; 17(6):566-572. PubMed ID: 25732625
    [Abstract] [Full Text] [Related]

  • 7. A randomized, placebo-controlled trial of beloranib for the treatment of hypothalamic injury-associated obesity.
    Shoemaker A, Proietto J, Abuzzahab MJ, Markovic T, Malloy J, Kim DD.
    Diabetes Obes Metab; 2017 Aug 01; 19(8):1165-1170. PubMed ID: 28261955
    [Abstract] [Full Text] [Related]

  • 8. Hyperphagia in male melanocortin 4 receptor deficient mice promotes growth independently of growth hormone.
    Tan HY, Steyn FJ, Huang L, Cowley M, Veldhuis JD, Chen C.
    J Physiol; 2016 Dec 15; 594(24):7309-7326. PubMed ID: 27558671
    [Abstract] [Full Text] [Related]

  • 9. Aspergillus, angiogenesis, and obesity: the story behind beloranib.
    Howland RH.
    J Psychosoc Nurs Ment Health Serv; 2015 Mar 15; 53(3):13-6. PubMed ID: 25751824
    [Abstract] [Full Text] [Related]

  • 10. Ascending dose-controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women.
    Hughes TE, Kim DD, Marjason J, Proietto J, Whitehead JP, Vath JE.
    Obesity (Silver Spring); 2013 Sep 15; 21(9):1782-8. PubMed ID: 23512440
    [Abstract] [Full Text] [Related]

  • 11. Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes.
    Raposinho PD, Castillo E, d'Alleves V, Broqua P, Pralong FP, Aubert ML.
    Endocrinology; 2000 Dec 15; 141(12):4419-27. PubMed ID: 11108250
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity.
    Stofkova A, Skurlova M, Kiss A, Zelezna B, Zorad S, Jurcovicova J.
    Endocr Regul; 2009 Jul 15; 43(3):99-106. PubMed ID: 19817504
    [Abstract] [Full Text] [Related]

  • 16. The mahoganoid mutation (Mgrn1md) improves insulin sensitivity in mice with mutations in the melanocortin signaling pathway independently of effects on adiposity.
    Phan LK, Chung WK, Leibel RL.
    Am J Physiol Endocrinol Metab; 2006 Sep 15; 291(3):E611-20. PubMed ID: 16638826
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Food motivated behavior of melanocortin-4 receptor knockout mice under a progressive ratio schedule.
    Vaughan C, Moore M, Haskell-Luevano C, Rowland NE.
    Peptides; 2006 Nov 15; 27(11):2829-35. PubMed ID: 16930774
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The hyperleptinemia and ObRb expression in hyperphagic obese rats.
    Han Y, Joe Y, Seo E, Lee SR, Park MK, Lee HJ, Kim DK.
    Biochem Biophys Res Commun; 2010 Mar 26; 394(1):70-4. PubMed ID: 20171169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.